Literature DB >> 10585292

Intracellular calcium puffs in osteoclasts.

W Radding1, S E Jordan, R B Hester, H C Blair.   

Abstract

We studied intracellular calcium ([Ca(2+)](i)) in acid-secreting bone-attached osteoclasts, which produce a high-calcium acidic extracellular compartment. Acid secretion and [Ca(2+)](i) were followed using H(+)-restricted dyes and fura-2 or fluo-3. Whole cell calcium of acid-secreting osteoclasts was approximately 100 nM, similar to cells on inert substrate that do not secrete acid. However, measurements in restricted areas of the cell showed [Ca(2+)](i) transients to 500-1000 nM consistent with calcium puffs, transient (millisecond) localized calcium elevations reported in other cells. Spot measurements at 50-ms intervals indicated that puffs were typically less than 400 ms. Transients did not propagate in waves across the cell in scanning confocal measurements. Calcium puffs occurred mainly over regions of acid secretion as determined using lysotracker red DND99 and occurred at irregular periods averaging 5-15 s in acid secreting cells, but were rare in lysotracker-negative nonsecretory cells. The calmodulin antagonist trifluoperazine, cell-surface calcium transport inhibitors lanthanum or barium, and the endoplasmic reticulum ATPase inhibitor thapsigargin had variable acute effects on the mean [Ca(2+)](i) and puff frequency. However, none of these agents prevented calcium puff activity, suggesting that the mechanism producing the puffs is independent of these processes. We conclude that [Ca(2+)](i) transients in osteoclasts are increased in acid-secreting osteoclasts, and that the puffs occur mainly near the acid-transporting membrane. Cell membrane acid transport requires calcium, suggesting that calcium puffs function to maintain acid secretion. However, membrane H(+)-ATPase activity was insensitive to calcium in the 100 nM-1 microM range. Thus, any effects of calcium puffs on osteoclastic acid transport must be indirect. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10585292     DOI: 10.1006/excr.1999.4714

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

Review 1.  Calcium signaling in osteoclasts.

Authors:  Sung-Yong Hwang; James W Putney
Journal:  Biochim Biophys Acta       Date:  2010-11-11

Review 2.  Calcium and bone disease.

Authors:  Harry C Blair; Lisa J Robinson; Christopher L-H Huang; Li Sun; Peter A Friedman; Paul H Schlesinger; Mone Zaidi
Journal:  Biofactors       Date:  2011-06-14       Impact factor: 6.113

Review 3.  Mechanisms balancing skeletal matrix synthesis and degradation.

Authors:  Harry C Blair; Mone Zaidi; Paul H Schlesinger
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

4.  A mathematical model of osteoclast acidification during bone resorption.

Authors:  Frank V Marcoline; Yoichi Ishida; Joseph A Mindell; Smita Nayak; Michael Grabe
Journal:  Bone       Date:  2016-09-17       Impact factor: 4.398

5.  The combination of calmodulin antagonists and interferon-gamma induces apoptosis through caspase-dependent and -independent pathways in cholangiocarcinoma cells.

Authors:  Eun-Young Ahn; George Pan; Jae Hwan Oh; Ewan M Tytler; Jay M McDonald
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

Review 6.  Calcium signalling and calcium transport in bone disease.

Authors:  H C Blair; P H Schlesinger; C L H Huang; M Zaidi
Journal:  Subcell Biochem       Date:  2007

7.  Necessity of inositol (1,4,5)-trisphosphate receptor 1 and mu-calpain in NO-induced osteoclast motility.

Authors:  Beatrice B Yaroslavskiy; Allison C Sharrow; Alan Wells; Lisa J Robinson; Harry C Blair
Journal:  J Cell Sci       Date:  2007-08-15       Impact factor: 5.285

Review 8.  Osteoclastic differentiation and function regulated by old and new pathways.

Authors:  Harry C Blair; Mone Zaidi
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 9.306

9.  Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathway.

Authors:  Tang Liu; Qing Zhang; Zhengxiao Ouyang; Xiaoning Guo; Xia Chen; Bo Liu; Qiang Zhang; Ziqing Yin; Zanjing Zhai; Xinhua Qu; Xuqiang Liu; Dan Peng; Yi Shen
Journal:  Oncotarget       Date:  2017-12-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.